SAN DIEGO — LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The…
In July 2021, John Loadsman received a manuscript about a clinical trial that immediately roused his suspicion. Then the editor-in-chief of Anaesthesia and Intensive Care, Loadsman asked the authors…
The criteria given to GPs to refer women at risk of breast cancer for further action miss nearly all under-50s who go on to develop the disease within a decade, analysis suggests.
The subluxation lives on in new chiropractic education standards. The post The Council on Chiropractic Education reaffirms the subluxation, backs off primary care (sort of) first appeared on…
The subluxation lives on in new chiropractic education standards. The post The Council on Chiropractic Education reaffirms the subluxation, backs off primary care (sort of) first appeared on…
